Clinical Trial Update: Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of docetaxel and carboplatin in relapsed stage III/IV ovarian epithelial cancer or primary peritoneal cancer; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Paraplatin (Carboplatin)
• Taxotere (docetaxel)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Ovarian Cancer, Peritoneal Cavity Cancer | Phase 2 | Status: COMPLETED